Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.8300 (-3.16%) ($5.6200 - $6.0800) on Tue. Jan. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.6% (three month average) | RSI | 53 | Latest Price | $5.8300(-3.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.7% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(66%) ARKK(63%) XBI(63%) IBB(58%) IPO(56%) | Factors Impacting CGEN price | CGEN will decline at least -1.8% in a week (0% probabilities). VXX(-37%) VIXM(-33%) UUP(-11%) TLT(-4%) SHY(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.8% (StdDev 3.6%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
Resistance Level | $5.94 | 5 Day Moving Average | $6.03(-3.32%) | 10 Day Moving Average | $6.02(-3.16%) | 20 Day Moving Average | $5.94(-1.85%) | To recent high | -6% | To recent low | 16.4% | Market Cap | $482m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |